You are here: Industry Insights > acquire

News List

Strides to acquire remaining stake in Vivimed biospectrumasia
January 31, 2019
Complements Strides’s front end led growth with a de-risked manufacturing base.
Hikma acquires Medlac Pharma biospectrum
November 12, 2018
Driven by a growing population, government healthcare reforms and strong economic development, Vietnam has been the fastest growing pharmaceutical market in South East Asia in recent years and this fast-paced growth is expected to continue.
Aussie firm Mayne to acquire Metrics biospectrumasia
October 29, 2018
Aussie firm Mayne to acquire Metrics
J & J announces Offer to Acquire Ci:z Holdings Co., Ltd. biospectrum
October 25, 2018
An acquisition is expected to Expand J&J's Consumer Portfolio of Science-based Dermocosmetic Beauty Products
Nutriband to Acquire Carmel Biosciences americanpharmaceuticalreview
September 27, 2018
Nutriband has signed the definitive acquisition agreement to acquire Carmel Biosciences. The acquisition is expected to be valued at approximately $2,700,000 and will be paid in company stock in the amount of 350,000 restricted common shares.
Allergan to Acquire Bonti americanpharmaceuticalreview
September 18, 2018
Allergan has agreed to acquire Bonti, a privately held clinical-stage biotechnology company focused on the development and commercialization of novel...
Eli Lilly to buy Armo BioSciences for US$1.6B biospectrumasia
May 14, 2018
Lilly gives an offer of US$50 per share, which represents a premium of 68 percent to Armo's Wednesday close.
Shandong to acquire Argon Medical Devices biospectrumasia
September 27, 2017
Once the purchase is complete, Argon will become one of Shandong Weigao’s core platforms for overseas expansion.
Gilead Sciences to buy Kite Pharma for $11.9bn pharmaceutical-technology
August 30, 2017
Biopharmaceutical company Gilead Sciences has entered a definitive agreement to acquire US-based Kite Pharma for approximately $11.9bn.
To Acquire Sinovac Biotech (Nasnaq: SVA) Sinobioway Consortium Raises Its Purchase Price To $8 Per S en-cphi.cn
July 03, 2017
To Acquire Sinovac Biotech (Nasnaq: SVA) Sinobioway Consortium Raises Its Purchase Price To $8 Per Share.

Previous page 1 2 3 4 5 Next page